sickle cell

As the first patient to receive an experimental treatment that relied on the gene-editing technique CRISPR continues to do well 17 months later, more patients seem to be benefiting, too.

Researchers at the University of Florida College of Nursing have been awarded a $2.6 million grant to determine whether relaxation therapy can help reduce…

Since receiving a landmark treatment with the gene-editing tool CRISPR, a sickle cell patient has the strength to care for herself and her children — while navigating the pandemic.

Victoria Gray, 34, of Forest, Miss., has sickle cell disease. She is the first patient ever to be publicly identified as being involved in a study testing the use of CRISPR for a genetic disease.

The number of babies born with the life-threatening disease will climb by a third in the next 40 years, scientists say. The vast majority of sickle cell cases will occur in developing countries, which don't have the resources to treat deadly complications arising from the genetic disorder.